--- title: "SDGR Schrodinger" canonical: "https://supercyclehq.com/stock/schrodinger" type: "stock" dataAsOf: "2026-11-06" ticker: "SDGR" license: "Free to use and quote with attribution to supercyclehq.com. Do not redistribute as a dataset." disclaimer: "Informational only, not investment advice. The AI Exposure Score is Supercycle's editorial opinion. Agent portfolios are simulated paper portfolios run by AI." --- # Schrodinger (SDGR) Schrodinger is a computational chemistry company. ## AI Exposure Score **75/100, Core.** Schrodinger licenses physics based computational chemistry software to pharma and uses the same platform for its own drug programs and partnerships. The whole franchise rests on simulation and ML replacing wet lab screening, so AI driven discovery is the thesis. ## Quote | Field | Value | | --- | --- | | Price (EOD close) | $29.82 | | Change 1d | +3.65% | | Change 7d | +9.87% | | Change 30d | +13.00% | | Change 1y | +67.72% | | 52-week high | $32.60 | | 52-week low | $11.07 | | Market cap | $2.2B | | P/E | n/a | | EPS | $-0.79 | | Next earnings | 2026-11-04 | Quote as of 2026-11-06. ## Company | Field | Value | | --- | --- | | Exchange | NASDAQ | | Sector | Healthcare | | Headquarters | New York, New York | | CEO | Ramy Farid | | Employees | 850 | | Website | https://www.schrodinger.com | | Buildout layers | [AI Healthcare](https://supercyclehq.com/category/ai-healthcare), [AI Software & Platforms](https://supercyclehq.com/category/ai-software) | ## What the company does Schrodinger is a computational chemistry company. It licenses physics based software that simulates how molecules behave, letting pharmaceutical and materials companies test drug candidates on computers instead of running every experiment in a wet lab. It also uses the same platform for its own drug programs and partnerships. Its products include the Schrodinger Platform for molecular simulation, FEP+ for predicting how tightly a drug binds its target, LiveDesign for collaborative drug design, and AI molecular simulations that combine physics models with machine learning. Founded in 1990 and headquartered in New York City, Schrodinger trades on the NASDAQ and employs about 850 people under CEO Ramy Farid. ## Role in the AI buildout Schrodinger sits in the AI Healthcare layer of the buildout, with a platform business in AI Software & Platforms. Its entire franchise rests on the idea that simulation and machine learning can replace wet lab screening in drug discovery, so computational methods are not a feature, they are the product. It monetizes this through software licenses to pharma and through its own drug programs, which is why Supercycle scores its AI exposure at 75 out of 100. ## Tracked investors holding it (13F) | Investor | Fund | Position value | Portfolio % | Change | Period | | --- | --- | --- | --- | --- | --- | | [Bill Gates](https://supercyclehq.com/investors/bill-gates) | Gates Foundation Trust | $113.5M | 0.33% | unchanged | 2026-06-30 | | [Cathie Wood](https://supercyclehq.com/investors/cathie-wood) | ARK Investment Management | $35.0M | 0.23% | increased | 2026-06-30 | ## Recent news - [Schrödinger, Inc. Q3 2026 Earnings Call Summary](https://app.moby.co/home/research/tools/earningsCalendar/earnings-schr%C3%B6dinger-inc-q3-2026-earnings-call-summary?utm_source=yahoo_finance&utm_medium=rss&.tsrc=rss) (source, 2026-11-05) - [What Schrodinger (SDGR) Said on Its Q3 Earnings Call](https://www.marketbeat.com/instant-alerts/transcript-what-schrodinger-sdgr-said-on-its-q3-earnings-call-2026-11-04/?utm_source=yahoofinance&utm_medium=yahoofinance&.tsrc=rss) (source, 2026-11-05) - [Schrodinger, Inc. (SDGR) Reports Q3 Loss, Beats Revenue Estimates](https://finance.yahoo.com/markets/stocks/articles/schrodinger-inc-sdgr-reports-q3-234521526.html?.tsrc=rss) (source, 2026-11-04) - [Schrödinger Reports Third Quarter 2026 Financial Results](https://finance.yahoo.com/healthcare/articles/schr-dinger-reports-third-quarter-210500524.html?.tsrc=rss) (source, 2026-11-04) - [Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline](https://finance.yahoo.com/markets/stocks/articles/earnings-preview-schrodinger-inc-sdgr-130016881.html?.tsrc=rss) (source, 2026-10-28) ## FAQ ### What does Schrodinger do? Schrodinger licenses physics based computational chemistry software that simulates molecular behavior, letting pharma companies test drug candidates digitally. It also runs its own drug discovery programs on the same platform. ### How is Schrodinger exposed to AI? Deeply. The whole franchise rests on simulation and machine learning replacing wet lab screening, so computational discovery is the thesis itself. Supercycle scores its AI exposure at 75 out of 100. ### What are Schrodinger's main products? The Schrodinger Platform for molecular simulation, FEP+ for binding predictions, LiveDesign for collaborative drug design, and AI molecular simulation tools that pair physics models with machine learning. ### Who leads Schrodinger and where is it based? CEO Ramy Farid leads the company from New York City. Founded in 1990, Schrodinger employs about 850 people and trades on the NASDAQ. ### What sector and categories is SDGR in? Schrodinger is a Healthcare sector company. On Supercycle it is categorized under AI Healthcare and AI Software & Platforms within the AI buildout map. --- Source: https://supercyclehq.com/stock/schrodinger. Data as of 2026-11-06. Prices are end-of-day closes, never live. Informational only, not investment advice. The AI Exposure Score is Supercycle's editorial opinion. Agent portfolios are simulated paper portfolios run by AI. Free to use and quote with attribution to supercyclehq.com. Do not redistribute as a dataset.